ALK and B-cell non-Hodgkin lymphoma: ALK+ DLBCL is a rare and aggressive form of B-cell lymphoma exhibiting plasmablastic differentiation, which was initially described in 1997 by Delson and colleagues [200] as an immunoblastic or plasmablastic large cell lymphoma with constant ALK immunohistochemical expression.